PVNCRF Neurons Regulate Migraine-Like Allodynia by Activating CRFR2 on Spinal Trigeminal Caudalis Glutamatergic Neurons
Abstract
Migraine is a prevalent and debilitating neurological disorder with poorly understood neural mechanisms. Here, we characterize a hypothalamic-trigeminal pathway involved in the regulation of migraine-like allodynia. Using a combination of monosynaptic circuit, fiber photometry-based calcium imaging, and behavioral assays in a nitroglycerin (NTG)-induced murine model, we observed hyperactivity in corticotropin-releasing factor (CRF)-expressing neurons within the hypothalamic paraventricular nucleus (PVN). Activation or inhibition of PVNCRF neurons mimicked or blocked migraine-like allodynia, respectively. These PVNCRF neurons modulated migraine-like allodynia by exciting glutamatergic neurons in the spinal trigeminal nucleus caudalis (SP5C). Furthermore, employing a CRF neurotransmitter fluorescent sensor, neuropharmacology, and electrophysiological recordings, we revealed that PVNCRF neurons excessively release CRF neuropeptides onto SP5CGlu neurons during migraine-like conditions. This led to hyperactivation of corticotropin-releasing factor receptor type 2 (CRFR2), but not type 1 (CRFR1), resulting in hyperalgesia. Blockade of CRFR2 within the SP5C significantly alleviated migraine-like allodynia. Complementing these findings, clinical functional magnetic resonance imaging (fMRI) of migraine patients indicated structural and functional alterations in PVN and SP5C regions associated with this pathway. Collectively, our results uncover a previously unappreciated…
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.